MEDIROM Healthcare Technologies
MRM
2 hedge funds and large institutions have $216 invested in MEDIROM Healthcare Technologies in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and closing their positions.
100% more funds holding
Funds holding: 1 → 2 (+1)
0.01% less ownership
Funds ownership: 0.01% → 0% (-0.01%)
91% less capital invested
Capital invested by funds: $2.5K → $216 (-$2.28K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$165 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$2.1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $118 | +$165 | +30 | New |
|
|
2
Bank of America
Charlotte,
North Carolina
| $98 | -$2.1K | -382 | -94% |
|
MRM Hedge Fund Activity: Q2 2024 in Review
2 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in MEDIROM Healthcare Technologies (MRM) for Q2 2024, worth a combined $216 — down 91% from $2.5K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new MRM positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $165. The largest seller was Bank of America, cutting an estimated $2.1K.
- 2 institutional investors held MEDIROM Healthcare Technologies (MRM) as of Q2 2024, up from 1 in Q1 2024.
- Funds reported $216 of MEDIROM Healthcare Technologies stock for Q2 2024, down 91% quarter-over-quarter.
- 1 fund opened new MEDIROM Healthcare Technologies positions in Q2 2024 and 0 closed out, a net change of +1 holder.
- The largest MEDIROM Healthcare Technologies buyer in Q2 2024 was UBS Group, an estimated $165 added.
- The largest MEDIROM Healthcare Technologies seller in Q2 2024 was Bank of America, an estimated $2.1K sold.
Based on aggregated 13F filings for Q2 2024.